ArticleThe oncologist2024

Comparison of the Response to Neoadjuvant Therapy Between Immunohistochemistry HER2 (3+) and HER2 (2+)/ISH+ Early-Stage Breast Cancer: A Retrospective Multicenter Cohort Study.

Dechuang Jiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.